Terms ending in 2028
Every in-force patent on Precision Biosciences, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,340,777 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,434,931 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | |
| US 10,041,053 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | |
| US 12,351,839 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | |
| US 8,445,251 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.